1-12 of 12
Mengyang Di
Close
Sort by
Journal Articles

Predictors of Outcome for Allogeneic Stem Cell Transplantation with a Reduced Intensity Pentostatin/TBI Conditioning Regimen in T-Cell Lymphomas: A Single Center Experience

Ramzi Hamouche, Francine M. Foss, Sayeef Mirza, Mengyang Di, Iris Isufi, Noffar Bar, Lohith Gowda, Sarah Perreault, Kenneth Roberts, Stuart Seropian, Tarsheen Sethi
Journal: Blood
Blood (2023) 142 (Supplement 1): 2172.
https://doi.org/10.1182/blood-2023-189414
Published: 2023
Journal Articles

Real-World Practice Patterns and Outcomes Following Bruton Tyrosine Kinase Inhibitors (BTKi) in Older Patients with Mantle Cell Lymphoma (MCL): A Population-Based Analysis

Mengyang Di, Jessica B Long, Shalin K. Kothari, Tarsheen Sethi, Amer M. Zeidan, Nikolai A. Podoltsev, Rory Michael Shallis, Rong Wang, Jessica M. Stempel, Xiaomei Ma, Scott F. Huntington
Journal: Blood
Blood (2022) 140 (Supplement 1): 10904–10906.
https://doi.org/10.1182/blood-2022-164959
Published: 2022
Journal Articles

Second Malignancies Among Older Patients with Classical Myeloproliferative Neoplasms Treated with Ruxolitinib

Jessica M. Stempel, Rong Wang, Rory Michael Shallis, Scott F. Huntington, Amer M. Zeidan, Natalia Neparidze, Mengyang Di, Xiaomei Ma, Nikolai A. Podoltsev
Journal: Blood
Blood (2022) 140 (Supplement 1): 11004–11006.
https://doi.org/10.1182/blood-2022-165156
Published: 2022
Journal Articles

Total Costs of Care during Chimeric Antigen Receptor T-Cell Therapy in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma: A Large Private Insurance Claim-Based Analysis

Mengyang Di, Jessica B Long, Iris Isufi, Francine M. Foss, Stuart Seropian, Cary P Gross, Scott F. Huntington
Journal: Blood
Blood (2022) 140 (Supplement 1): 10818–10819.
https://doi.org/10.1182/blood-2022-164915
Published: 2022
Journal Articles

Contemporary "Real World" Molecular Testing and Tyrosine Kinase Inhibitor Adherence Patterns Among Older Pts with Chronic Myeloid Leukemia in the United States

Rory M. Shallis, Rong Wang, Amer M. Zeidan, Scott F. Huntington, Natalia Neparidze, Mengyang Di, Xiaomei Ma, Nikolai Podoltsev
Journal: Blood
Blood (2021) 138 (Supplement 1): 282.
https://doi.org/10.1182/blood-2021-151066
Published: 2021
Journal Articles

Survival of Mantle Cell Lymphoma in the Era of Bruton Tyrosine Kinase Inhibitors: A Population-Based Analysis

Mengyang Di, Can Cui, Shalin K. Kothari, Amer M. Zeidan, Nikolai Podoltsev, Natalia Neparidze, Rory M. Shallis, Rong Wang, Xiaomei Ma, Scott F. Huntington
Journal: Blood
Blood (2021) 138 (Supplement 1): 182.
https://doi.org/10.1182/blood-2021-146417
Published: 2021
Journal Articles

Functional Status and Therapy for Nursing Home Residents with Diffuse Large B-Cell Lymphoma: A Population-Based Study

Mengyang Di, Adam J. Olszewski, Tamra Keeney, Emmanuelle Belanger, Orestis A. Panagiotou
Journal: Blood
Blood (2021) 138 (Supplement 1): 1918.
https://doi.org/10.1182/blood-2021-146498
Published: 2021
Journal Articles

Functional Status and Therapy for Older Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Population-Based Study

Mengyang Di, MD PhD, Tamra Keeney, DPT, PhD, Emmanuelle Belanger, PhD, Orestis A. Panagiotou, MD PhD, Adam J Olszewski, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-137714
Published: 2020
Journal Articles

Cost-Effectiveness of Once-Weekly Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Twice-Weekly Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma

Kishan Patel, BS, Terri L. Parker, MD, Mengyang Di, MD PhD, Noffar Bar, MD, Scott F. Huntington, MD MPH, Smith Giri, MDMS
Journal: Blood
Blood (2020) 136 (Supplement 1): 51–52.
https://doi.org/10.1182/blood-2020-141972
Published: 2020
Journal Articles

Geographic Variation in the Incidence of Marginal Zone Lymphoma Subtypes and Infectious Risk Factors in the United States

Mengyang Di, MD PhD, Adam J Olszewski, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4012.
https://doi.org/10.1182/blood-2019-122361
Published: 2019
Journal Articles

Exposure to Ibritumomab Tiuxetan and Incidence of Treatment-Related Myeloid Neoplasms Among Older Patients with B-Cell Lymphoma: A Population-Based Study

Mengyang Di, MD PhD, Thomas A Ollila, MD, Adam J Olszewski, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3477.
https://doi.org/10.1182/blood-2019-121959
Published: 2019
Journal Articles

Adjuvant Chemotherapy Administration and Survival Outcomes in Lymphoma Survivors with Common Solid Tumors: A Population-Based Study

Mengyang Di, MD PhD, Adam J Olszewski, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 621.
https://doi.org/10.1182/blood-2018-99-114250
Published: 2018